Recent Advances in Library Synthesis to Accelerate Medicinal Chemistry Research

Learn how parallel medicinal chemistry (PMC) and high throughput experimentation (HTE) combined with machine learning can provide a more focused approach to target molecules, resulting in a more concentrated set of compounds to make the process of lead selection easier.

Our experts show how PMC can shorten the turnaround time of the design-synthesis-test cycle, providing more compounds with limited scaffolds by using streamlined workflows and accumulated parallel synthesis knowledge.

Check out our comprehensive platform of discovery chemistry services

← Return to Resources

Related Content

Indoleamine 2,3-dioxygenase 1 (IDO1) is an enzyme that metabolizes tryptophan, and its activity can lead to immunosuppression, thereby allowing tumors...

VIEW RESOURCE

Tuberculosis is the leading cause of death from an infectious disease and is caused by Mycobacterium tuberculosis (MTB). Inosine-5′-monophosphate dehydrogenase...

VIEW RESOURCE
← View all Discovery Chemistry Resources
× peptide, amino acid

Contact An Expert Today!